Please login to the form below

Not currently logged in

pancreatic adenocarcinoma.

This page shows the latest pancreatic adenocarcinoma. news and features for those working in and with pharma, biotech and healthcare.

EU green light for Novartis' skin cancer therapy

EU green light for Novartis' skin cancer therapy

Other studies of the drug are ongoing in prostate cancer, pancreatic adenocarcinoma, ovarian cancer, non-small cell lung cancer and triple-negative breast cancer, as well as haematological malignancies such as

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Enablers of drug innovation could lie in the numbers

    Take the pancreatic adenocarcinoma scenario for example, if the drug developers had targeted their research in Europe instead of the USA, one could have found a much more favourable research environment. ... 7)  EpiomicTM Patient Segmentation Database,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...